• Users Online: 296
  • Print this page
  • Email this page

 Table of Contents  
Year : 2021  |  Volume : 1  |  Issue : 4  |  Page : 823-824

Central serous chorioretinopathy in a silicone oil-filled eye

Smt Kanuri Santhamma Center for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Hyderabad, Telangana, India

Date of Submission23-Nov-2020
Date of Acceptance04-May-2021
Date of Web Publication09-Oct-2021

Correspondence Address:
Dr. Mudit Tyagi
Smt Kanuri Santhamma Center for Vitreo-retina Services, L. V. Prasad Eye Institute, Hyderabad - 500 034, Telangana
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijo.IJO_3458_20

Rights and Permissions

Keywords: Central serous chorioretinopathy, silicone oil, vitreoretinal surgery

How to cite this article:
Reddy S, Tyagi M, Jhingan M, Chhablani J. Central serous chorioretinopathy in a silicone oil-filled eye. Indian J Ophthalmol Case Rep 2021;1:823-4

How to cite this URL:
Reddy S, Tyagi M, Jhingan M, Chhablani J. Central serous chorioretinopathy in a silicone oil-filled eye. Indian J Ophthalmol Case Rep [serial online] 2021 [cited 2021 Oct 28];1:823-4. Available from: https://www.ijoreports.in/text.asp?2021/1/4/823/327671

A 45-year-old healthy male with a visual acuity of counting finger 1 m underwent a 25 gauge pars plana vitrectomy along with IOL explantation and a silicone oil endotamponade for posteriorly dislocated IOL and rhegmatogenous retinal detachment. At 1 week follow-up, the vision in the left eye had improved to 20/200. A retinal evaluation of the left eye showed attached retina under silicone oil. However, an elevated serous detachment of neurosensory retina was noted at this visit [Figure 1]a and [Figure 1]b. Optical coherence tomography (OCT) of the left eye showed a large dome-shaped serous detachment of neurosensory retina [Figure 2]a. Fundus fluorescein angiography of the left eye showed a characteristic expanding dot-like pattern of leak [Figure 2]b and [Figure 2]c superonasal to fovea suggestive of CSCR. All systemic risk factors were ruled out after taking meticulous history.
Figure 1: (a) Color fundus photograph of the left eye showing silicone oil-filled eye with an elevated serous detachment of neurosensory retina (yellow arrow) at macula better appreciated in red-free photograph Figure 1b (outline)

Click here to view
Figure 2: (a) OCT of the left eye at postoperative 1-week follow-up showing elevated dome-shaped serous detachment of neurosensory retina (yellow arrow). FFA of the left eye early (b) and late arteriovenous phase (c) showing expanding dot pattern (yellow arrow) of leakage with optic disc leakage

Click here to view

In this case, topical corticosteroids were the only factor that we could attribute to be a risk factor for CSCR. Therefore, topical corticosteroids were discontinued and were substituted with topical non-steroidal anti-inflammatory agents (NSAIDs). At 2 months, the BCVA had improved to 20/40. The serous detachment had regressed on OCT suggestive of resolution of CSCR [Figure 3]a and [Figure 3]b. Silicone oil removal along with secondary glued IOL implantation was done subsequently.
Figure 3: (a and b) Fundus photograph and OCT of the left eye, respectively, at 2-month follow-up showing complete resolution of serous detachment at macula

Click here to view

  Discussion Top

The main risk factors for CSCR include exogenous corticosteroid usage or endogenous hypercortisolism, type A personality, and pregnancy.[1],[2],[3] Corticosteroids through various routes (oral, intravenous, periocular, or intranasal) are known to cause CSCR.[4],[5],[6],[7],[8] Chang et al.[9] described an association between topical ophthalmic corticosteroids and CSCR. Moreno-López et al.[10] reported a case of persistent subretinal fluid due to central serous chorioretinopathy (the patient had used topical steroids for 5 weeks) after 5 months of retinal detachment surgery; however, authors did not contribute the occurrence of CSCR to topical steroids. Therefore, it may be prudent to consider discontinuation of the offending risk factor in such cases.

This case describes a rare occurrence of CSR in a silicone oil-filled eye which resolved spontaneously after 2 months.

Financial support and sponsorship

Support provided by Hyderabad Eye Research Foundation, Hyderabad, India.

Conflicts of interest

There are no conflicts of interest.

  References Top

Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: Update on pathophysiology and treatment. Surv Ophthalmol 2013;58:103-26.  Back to cited text no. 1
Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: A review of epidemiology and pathophysiology. Clin Exp Ophthalmol 2013;41:201-14.  Back to cited text no. 2
Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, et al. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog Retin Eye Res 2015;48:82-118.  Back to cited text no. 3
Tsai D-C, Chen S-J, Huang C-C, Chou P, Chung C-M, Chan W-L, et al. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: A population-based study in Taiwan. Retina 2014;34:1867-74.  Back to cited text no. 4
Grixti A, Kumar V. Steroid induced central serous chorioretinopathy in giant cell arteritis. Case Rep Ophthalmol Med 2013;2013:924037.  Back to cited text no. 5
Baumal CR, Martidis A, Truong SN. Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27 associated iritis. Arch Ophthalmol 2004;122:926-8.  Back to cited text no. 6
Kleinberger AJ, Patel C, Lieberman RM, Malkin BD. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: A case report and review of the literature. Laryngoscope 2011;121:2034-7.  Back to cited text no. 7
Araki T, Ishikawa H, Iwahashi C, Niki M, Mitamura Y, Sugimoto M, et al. Central serous chorioretinopathy with and without steroids: A multicenter survey. PLoS One 2019;14:e0213110.  Back to cited text no. 8
Chang YS, Weng SF, Chang C, Wang JJ, Wang JY, Jan RL. Associations between topical ophthalmic corticosteroids and central serous chorioretinopathy: A Taiwanese population-based study. Invest Ophthalmol Vis Sci 2015;56:4083-9.  Back to cited text no. 9
Moreno-López M, Pérez-López M, Casas-Llera P, Jarrín E, Muñoz-Negrete FJ. Persistent subretinal fluid due to central serous chorioretinopathy after retinal detachment surgery. Clin Ophthalmol 2011;5:1465-7.  Back to cited text no. 10


  [Figure 1], [Figure 2], [Figure 3]


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article
Article Figures

 Article Access Statistics
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal